SecBot SecBot
6-K ·Filed Aug 20, 2026

ICLR

ICON PLC
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago SEC0001628280-26-058141
Actionable Insight • Neutral

This ESG report is non-material for trading. The more significant event remains the May 2026 20-F restatement and material weakness disclosure; monitor for any subsequent auditor changes, SEC inquiries, or further restatements.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$174.27
T+0 close · Aug 20, 2026 · via day close
Latest settled
+15.06%
T+60 · $200.51
Vs SPY
+15.89%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 20 $174.27entry
  2. T+1 · 3mo ago −1.17%α −1.58% · $172.23
  3. T+5 · 3mo ago −2.61%α −3.73% · $169.72
  4. T+20 · 2mo ago −2.63%α −2.63% · $169.68
  5. T+60 · 4d ago +15.06%α +15.89% · $200.51
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

ICON plc filed its 2025 ICON Cares ESG report via a 6-K, detailing environmental, social, and governance progress. The report highlights operational metrics like renewable electricity usage and emissions reductions, but contains no financial data, guidance, or material business updates. This is a routine ESG disclosure with no stock-moving content, filed against the backdrop of a prior restatement and material weakness disclosure from the May 2026 20-F.

Key Facts

  • ICON released its 2025 ICON Cares ESG report on August 20, 2026.
  • The report notes a 73.56% reduction in Scope 1 and 2 GHG emissions vs. 2019 baseline, exceeding SBTi targets.
  • 97.05% of global electricity consumption in 2025 came from renewable sources.
  • ICON supported over 1,370 clinical studies involving more than 411,400 patients in 2025.
  • No financial data, revenue, earnings, guidance, or material business developments are included in this filing.
  • This filing follows a May 2026 20-F that restated FY2023 and FY2024 financials due to improper revenue recognition and disclosed material weaknesses in internal controls.

Financial Impact

No financial impact, ESG report only, no financial data disclosed.

Risk Factors

  • No new risks introduced by this filing; the existing risks from the prior restatement (revenue recognition, internal control weaknesses) remain the primary concern.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Commercial Physical & Biological Research
Analyst Consensus
67% bullish (24 analysts)

Investment Themes

Documents Analyzed

This report is based on 10 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (ICLR), Batch item 10001628280-26-058141
Document: iconcares2025reportpressre.htm0001628280-26-058141
Document: 0001628280-26-058141-index-headers.html0001628280-26-058141
Document: 0001628280-26-058141-index.html0001628280-26-058141
Document: 0001628280-26-058141.txt0001628280-26-058141
6-K Filing (ICLR), Batch item 60001628280-26-058141
Document: iconcares2025reportpressre.htm0001628280-26-058141
Document: 0001628280-26-058141-index-headers.html0001628280-26-058141
Document: 0001628280-26-058141-index.html0001628280-26-058141
Document: 0001628280-26-058141.txt0001628280-26-058141

Track record

25 reports on ICLR

Performance horizon

4 of 8 bullish or bearish reports moved the stock their way by T+1. Best: +33.70% at T+60 after the Aug 6, 2026 report. 5 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $190.43 Now $194.65 +2.22% settles Nov 17
  2. Nov 12, 20264d ago 144 Neutral 2/10 Entry $194.65 to $191.40 Now $194.65 −0.00% ▼ −1.67% +0.24% vs SPY
  3. Nov 10, 20266d ago 6-K Neutral 2/10 Entry $204.63 to $199.70 Now $194.65 −4.88% ▼ −2.41% −3.73% vs SPY
  4. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $201.65 to $204.74 Now $194.65 −3.47% ▲ +1.53% +1.22% vs SPY
  5. Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $203.11 to $201.65 Now $194.65 −4.17% ▼ −0.72% +3.69% vs SPY
  6. Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $203.11 to $201.65 Now $194.65 −4.17% ▼ −0.72% +3.69% vs SPY
  7. Nov 2, 202614d ago 144 Neutral 2/10 Entry $203.77 to $203.11 Now $194.65 −4.48% ▼ −0.32% −1.98% vs SPY
  8. Nov 2, 202614d ago 144 Neutral 2/10 Entry $203.77 to $203.11 Now $194.65 −4.48% ▼ −0.32% −1.98% vs SPY
  9. Nov 2, 202614d ago 144 Neutral 2/10 Entry $203.77 to $203.11 Now $194.65 −4.48% ▼ −0.32% −1.98% vs SPY
  10. Oct 27, 202620d ago 6-K Bearish 5/10 Entry $214.16 to $215.48 Now $194.65 +9.11% ▼ −0.62% −1.00% vs SPY
Showing 10 of 25

US Market Status

Market Closed · Opens Wed (12h 58m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 20, 2026